SurModics Inc - Asset Resilience Ratio
SurModics Inc (SRDX) has an Asset Resilience Ratio of 3.80% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SRDX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how SurModics Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see SurModics Inc assets under control.
Liquid Assets Composition Over Time
This chart breaks down SurModics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore how much of SurModics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $6.45 Million | 3.8% |
| Total Liquid Assets | $6.45 Million | 3.80% |
Asset Resilience Insights
- Limited Liquidity: SurModics Inc maintains only 3.80% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
SurModics Inc Industry Peers by Asset Resilience Ratio
Compare SurModics Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for SurModics Inc (1999–2024)
The table below shows the annual Asset Resilience Ratio data for SurModics Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-09-30 | 2.24% | $4.00 Million | $178.56 Million | +0.12pp |
| 2023-09-30 | 2.12% | $3.93 Million | $185.73 Million | -- |
| 2022-09-30 | 0.00% | $0.00 | $158.36 Million | -- |
| 2021-09-30 | 3.97% | $7.72 Million | $194.59 Million | -14.00pp |
| 2020-09-30 | 17.96% | $30.31 Million | $168.76 Million | +2.37pp |
| 2019-09-30 | 15.60% | $24.93 Million | $159.87 Million | -9.60pp |
| 2018-09-30 | 25.19% | $41.35 Million | $164.13 Million | +1.91pp |
| 2017-09-30 | 23.28% | $31.80 Million | $136.59 Million | +6.76pp |
| 2016-09-30 | 16.52% | $21.95 Million | $132.89 Million | -- |
| 2015-09-30 | 0.00% | $0.00 | $100.21 Million | -- |
| 2014-09-30 | 2.90% | $3.04 Million | $104.89 Million | -7.12pp |
| 2013-09-30 | 10.02% | $10.21 Million | $101.92 Million | -3.57pp |
| 2012-09-30 | 13.59% | $14.12 Million | $103.87 Million | +4.23pp |
| 2011-09-30 | 9.36% | $15.23 Million | $162.65 Million | +4.01pp |
| 2010-09-30 | 5.35% | $9.11 Million | $170.28 Million | +0.53pp |
| 2009-09-30 | 4.81% | $8.93 Million | $185.56 Million | -0.03pp |
| 2008-09-30 | 4.84% | $9.25 Million | $191.03 Million | -2.45pp |
| 2007-09-30 | 7.29% | $12.50 Million | $171.33 Million | -27.69pp |
| 2006-09-30 | 34.98% | $55.06 Million | $157.40 Million | +18.46pp |
| 2005-09-30 | 16.52% | $20.52 Million | $124.22 Million | +1.49pp |
| 2004-09-30 | 15.04% | $16.51 Million | $109.78 Million | +12.34pp |
| 2003-09-30 | 2.70% | $2.64 Million | $97.81 Million | -2.40pp |
| 2002-09-30 | 5.10% | $3.94 Million | $77.25 Million | -4.46pp |
| 2001-09-30 | 9.57% | $5.80 Million | $60.58 Million | -21.66pp |
| 2000-09-30 | 31.23% | $15.85 Million | $50.75 Million | +19.04pp |
| 1999-09-30 | 12.19% | $3.90 Million | $32.00 Million | -- |
About SurModics Inc
Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more